Disease | cholelithiasis |
Phenotype | C0035078|renal failure |
Sentences | 1 |
PubMedID- 20880342 | Recent studies show a potential benefit of ezetimibe in treating insulin resistance, non-alcoholic fatty liver disease (nafld), gallstones and dyslipidaemia associated with chronic renal failure and organ transplantation. |
Page: 1